Literature DB >> 1120396

Relationship between digoxin concentrations in serum and saliva.

D H Huffman.   

Abstract

The concentration of digoxin in serum and saliva was determined in 18 patients receiving digoxin. Unlike serum, it was necessary to extract saliva with chloroform in order to quantitate digoxin levels accurately. An excellent linear correlation (r = +0.988, p less than 0.001) was observed between the saliva and serum digoxin concentrations. This indicates that saliva digoxin concentrations can be used to monitor digoxin therapy, particularly in patients in whom blood sampling is inconvenient or difficult. The saliva/serum ratio for digoxin concentration was 0.78 plus or minus 0.07 (SD). Since the digoxin binding to plasma proteins is 23%, it is the free drug that is in equilibrium between serum and saliva.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1120396     DOI: 10.1002/cpt1975173310

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  13 in total

1.  Salivary digoxin concentrations.

Authors:  P H Joubert; F O Müller; B N Aucamp
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

2.  Salivary antipyrine half-life: a useful measure of hepatic drug metabolism.

Authors:  P M Brooks; M A Bell; H Burns
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

Review 3.  Therapeutic drug monitoring in saliva.

Authors:  M Danhof; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

4.  Digoxin concentrations in serum and saliva: relationship to ECG changes and dosage in healthy volunteers.

Authors:  P H Joubert; B N Aucamp; F O Müller
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

Review 5.  Oral absorption and secretion of drugs.

Authors:  C F Speirs
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

6.  A descriptive systematic review of salivary therapeutic drug monitoring in neonates and infants.

Authors:  Laura Hutchinson; Marlene Sinclair; Bernadette Reid; Kathryn Burnett; Bridgeen Callan
Journal:  Br J Clin Pharmacol       Date:  2018-03-25       Impact factor: 4.335

7.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

8.  Pharmacokinetic investigations in man of two acetyl derivatives of 16alpha-gitoxin.

Authors:  K O Haustein
Journal:  Eur J Clin Pharmacol       Date:  1977-12-28       Impact factor: 2.953

9.  Serum, tear and salivary concentrations of methotrexate in man.

Authors:  W H Steele; J F Stuart; B Whiting; J R Lawrence; K C Calman; J G McVie; G M Baird
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

10.  Serum and saliva levels of a trimethoprim-sulfamethopyrazine combination in man.

Authors:  A Sardi; M P Vettaro; R Alesina; S Grasso; G Meinardi; I de Carneri; V Tamassia
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.